A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder

Journal of Clinical Psychopharmacology

Volumn 21, Issue 4, 2001, Pages 360-368

  Janicak, Philip G ^a,e   Keck Jr, Paul E ^b   Davis, John M ^a   Kasckow, John W ^d   Tugrul, Karen ^b   Dowd, Sheila M ^c   Strong, Jane ^a   Sharma, Rajiv P ^a   Strakowski, Stephen M ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Rush Psychiat Clin Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; RISPERIDONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOIDISM; SIDE EFFECT; STATISTICAL ANALYSIS;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISPERIDONE;

EID: 0034917997     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200108000-00002     Document Type: Article

References (35)

1. The structured clinical interview for DSM-III-R (SCID). II. Multisite test-retest reliability
2. Pharmacologic treatment of schizoaffective disorder
3. Schizoaffective psychosis. I. Comparative long-term outcome
4. Stability of diagnoses in affective, schizoaffective and schizophrenic disorders
5. An 8-year follow-up of patients with DSM-III-R psychotic depression, schizoaffective disorder, and schizophrenia
6. New developments in the pharmacologic treatment of schizoaffective disorder
7. Schizoaffective disorder: Role of atypical antipsychotics
8. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia
9. Clozapine therapy in refractory affective disorders: Polarity predicts response in long-term follow-up
10. Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome - A functional approach
11. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder
12. Risperidone therapy in treatment refractory acute bipolar and schizoaffective mania
13. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses
14. Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome
15. Risperidone in the treatment of schizophrenia
16. The effects of risperidone on five dimensions of schizophrenia derived by factor analysis combined results of the North American trials
17. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients
18. Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties
19. Treatment of schizoaffective disorder and schizophrenia with mood symptoms
20. The positive and negative syndrome scale (PANSS) for schizophrenia
21. The Clinician-Administered Rating Scale for Mania (CARS-M): Development, reliability and validity
22. A rating scale for depression
23. A rating scale for extrapyramidal side effects
24. Statistical methods for rates and proportions. 2nd ed.
25. Estimating mediated effects of effects in prevention studies
26. A simulation study of mediated effect measures
27. The effects of nefazodone on sleep architecture in depression
28. Increased deep sleep after trazodone use: A double-blind placebo-controlled study in healthy young adults
29. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder
30. Risperidone in chronic schizophrenic patients: An open study of the effect on the sleep architecture and clinical symptomatology
31. Principles and practice of psychopharmacotherapy. 3rd ed.
32. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders
33. An overview of the treatment of schizoaffective disorder